Literature DB >> 17505685

Predictors of quality-of-life improvement following pulmonary resection due to lung cancer.

Ivete Alonso Bredda Saad1, Neury José Botega, Ivan Felizardo Contrera Toro.   

Abstract

CONTEXT AND
OBJECTIVE: There is increasing involvement of health professionals in organizing protocols to determine the impact of lung surgery on functional state and activities of daily living, with the aim of improving quality of life (QoL). The objective of this study was to investigate predictors of QoL improvement among patients undergoing parenchyma resection due to lung cancer. DESIGN AND
SETTING: Prospective study, at teaching hospital of Universidade Estadual de Campinas (Unicamp).
METHODS: 36 patients with lung cancer diagnosis were assessed before surgery and on the 30th, 90th and 180th days after surgery. The Short-Form Health Survey (SF-36) was used as the dependent variable. The independent variables were the Hospital Anxiety and Depression (HAD) scale, a six-minute walking test (6-MWT), a visual analogue scale for pain, forced vital capacity (FVC), type of surgery and use of radiotherapy and chemotherapy. Generalized estimation equations (GEE) were utilized.
RESULTS: The median age for these 20 men and 16 women was 55.5 +/- 13.4 years. Both FVC and 6-MWT were predictors of improvement in the physical dimensions of QoL (p = 0.011 and 0.0003, respectively), as was smaller extent of surgical resection (p = 0.04). The social component of QoL had improved by the third postoperative month (p = 0.0005).
CONCLUSION: The predictors that affected QoL positively were better FVC and 6-MWT results and less extensive lung resection. Three months after the surgery, an improvement in social life was already seen.

Entities:  

Mesh:

Year:  2007        PMID: 17505685     DOI: 10.1590/s1516-31802007000100009

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  9 in total

1.  Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma.

Authors:  Takashi Tanaka; Shinichiro Morishita; Masaki Hashimoto; Yusuke Itani; Satoshi Mabuchi; Norihiko Kodama; Seiki Hasegawa; Kazuhisa Domen
Journal:  Support Care Cancer       Date:  2017-03-14       Impact factor: 3.603

Review 2.  Patient-Reported Physical Function Measures in Cancer Clinical Trials.

Authors:  Thomas M Atkinson; Angela M Stover; Daniel F Storfer; Rebecca M Saracino; Thomas A D'Agostino; Denise Pergolizzi; Konstantina Matsoukas; Yuelin Li; Ethan Basch
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

3.  The acceptance of illness, the intensity of pain and the quality of life in patients with lung cancer.

Authors:  Mariusz Chabowski; Jacek Polański; Beata Jankowska-Polanska; Katarzyna Lomper; Dariusz Janczak; Joanna Rosinczuk
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

4.  Pain and Anxiety versus Sense of Family Support in Lung Cancer Patients.

Authors:  Dimitra Lekka; Argiro Pachi; Athanasios Tselebis; Georgios Zafeiropoulos; Dionisios Bratis; Argiri Evmolpidi; Ioannis Ilias; Athanasios Karkanias; Georgios Moussas; Nikolaos Tzanakis; Konstantinos N Syrigos
Journal:  Pain Res Treat       Date:  2014-07-13

5.  Precision-Exercise-Prescription in patients with lung cancer undergoing surgery: rationale and design of the PEP study trial.

Authors:  Paul C LaStayo; Thomas K Varghese; Cornelia M Ulrich; Caroline Himbert; Kenneth Boucher; David W Wetter; Rachel Hess; Jaewhan Kim; Kelly Lundberg; Jennifer A Ligibel; Christopher A Barnes; Bailee Rushton; Robin Marcus; Samuel R G Finlayson
Journal:  BMJ Open       Date:  2018-12-16       Impact factor: 2.692

Review 6.  Recent trends in Brazilian medical research. An overview.

Authors:  Mauricio Rocha-e-Silva
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

Review 7.  Functional capacity, physical activity and muscle strength assessment of individuals with non-small cell lung cancer: a systematic review of instruments and their measurement properties.

Authors:  Catherine L Granger; Christine F McDonald; Selina M Parry; Cristino C Oliveira; Linda Denehy
Journal:  BMC Cancer       Date:  2013-03-20       Impact factor: 4.430

8.  Which field walking test should be used to assess functional exercise capacity in lung cancer? An observational study.

Authors:  Catherine L Granger; Linda Denehy; Selina M Parry; Joel Martin; Tim Dimitriadis; Maeve Sorohan; Louis Irving
Journal:  BMC Pulm Med       Date:  2015-08-12       Impact factor: 3.317

9.  The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer.

Authors:  Ramon Andrade de Mello; Mónica Ferreira; Filipa Soares-Pires; Sandra Costa; João Cunha; Pedro Oliveira; Venceslau Hespanhol; Rui Manuel Reis
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.